{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:18:10Z","timestamp":1789719490287,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602595"],"award-info":[{"award-number":["81602595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8151570"],"award-info":[{"award-number":["8151570"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002912","name":"Government of Guangdong Province","doi-asserted-by":"publisher","award":["2018A050506083"],"award-info":[{"award-number":["2018A050506083"]}],"id":[{"id":"10.13039\/501100002912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002912","name":"Government of Guangdong Province","doi-asserted-by":"publisher","award":["2017A010105014"],"award-info":[{"award-number":["2017A010105014"]}],"id":[{"id":"10.13039\/501100002912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016588","name":"Shenzhen Research Institute, City University of Hong Kong","doi-asserted-by":"publisher","award":["JCYJ20170818142053544"],"award-info":[{"award-number":["JCYJ20170818142053544"]}],"id":[{"id":"10.13039\/100016588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A010105014"],"award-info":[{"award-number":["2017A010105014"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A050506083"],"award-info":[{"award-number":["2018A050506083"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.intimp.2020.106500","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T19:03:38Z","timestamp":1587150218000},"page":"106500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The antipsychotic drug pimozide inhibits IgE-mediated mast cell degranulation and migration"],"prefix":"10.1016","volume":"84","author":[{"given":"Yi-Bo","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Fu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Tong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunmei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2020.106500_b0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ. J."},{"issue":"2","key":"10.1016\/j.intimp.2020.106500_b0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/all.13305","article-title":"Drug repurposing to treat asthma and allergic disorders: Progress and prospects","volume":"73","author":"Kruse","year":"2018","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.intimp.2020.106500_b0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nri3830","article-title":"The impact of diet on asthma and allergic diseases","volume":"15","author":"Julia","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106500_b0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jep.2012.12.046","article-title":"Morus bombycis extract suppresses mast cell activation and IgE-mediated allergic reaction in mice","volume":"146","author":"Kim","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106500_b0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12967-019-2026-9","article-title":"CDK4\/6 inhibitor palbociclib suppresses IgE-mediated mast cell activation","volume":"17","author":"Hou","year":"2019","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2020.106500_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.intimp.2020.106500_b0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s40265-015-0416-8","article-title":"Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention","volume":"75","author":"Hostalek","year":"2015","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.intimp.2020.106500_b0040","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/eji.201847706","article-title":"Metformin inhibits IgE- and aryl hydrocarbon receptor-mediated mast cell activation in vitro and in vivo","volume":"48","author":"Wang","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2020.106500_b0045","doi-asserted-by":"crossref","first-page":"10135","DOI":"10.18632\/oncotarget.20807","article-title":"Metformin and berberine, two versatile drugs in treatment of common metabolic diseases","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.intimp.2020.106500_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2019.02.041","article-title":"Berberine suppresses mast cell-mediated allergic responses via regulating FcepsilonRI-mediated and MAPK signaling","volume":"71","author":"Fu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106500_b0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1358\/dot.2014.50.2.2097801","article-title":"Current pharmacotherapeutic approaches for the treatment of Tourette syndrome","volume":"50","author":"Egolf","year":"2014","journal-title":"Drugs Today (Barc)."},{"issue":"11","key":"10.1016\/j.intimp.2020.106500_b0060","doi-asserted-by":"crossref","first-page":"17593","DOI":"10.18632\/oncotarget.4307","article-title":"The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget."},{"issue":"1","key":"10.1016\/j.intimp.2020.106500_b0065","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3892\/ijo.2015.3229","article-title":"The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation","volume":"48","author":"Zhou","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2020.106500_b0070","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3389\/fphar.2019.01517","article-title":"Pimozide Inhibits the Human Prostate Cancer Cells Through the Generation of Reactive Oxygen Species","volume":"10","author":"Kim","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106500_b0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41419-020-2335-1","article-title":"Suppressing STAT5 signaling affects osteosarcoma growth and stemness","volume":"11","author":"Subramaniam","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2020.106500_b0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.lfs.2018.08.027","article-title":"Pimozide suppresses colorectal cancer via inhibition of Wnt\/beta-catenin signaling pathway","volume":"209","author":"Ren","year":"2018","journal-title":"Life Sci."},{"issue":"7\u20138","key":"10.1016\/j.intimp.2020.106500_b0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/1947601912466555","article-title":"The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations","volume":"3","author":"Nelson","year":"2012","journal-title":"Genes Cancer."},{"issue":"12","key":"10.1016\/j.intimp.2020.106500_b0090","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"Nelson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.106500_b0095","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fimmu.2012.00130","article-title":"Cytoskeleton in mast cell signaling","volume":"3","author":"Draber","year":"2012","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106500_b0100","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.4049\/jimmunol.167.4.2298","article-title":"Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase","volume":"167","author":"Ishizuka","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106500_b0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4939-7896-0_8","article-title":"The Use of Human and Mouse Mast Cell and Basophil Cultures to Assess Type 2 Inflammation","volume":"1799","author":"Caslin","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2020.106500_b0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bcp.2018.05.012","article-title":"Repositioning of anti-cancer drug candidate, AZD7762, to an anti-allergic drug suppressing IgE-mediated mast cells and allergic responses via the inhibition of Lyn and Fyn","volume":"154","author":"Park","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2020.106500_b0115","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.3390\/ijms19124092","article-title":"Alisol B 23-Acetate Inhibits IgE\/Ag-Mediated Mast Cell Activation and Allergic Reaction","volume":"19","author":"Shao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2020.106500_b0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fphar.2018.00591","article-title":"Elaeocarpusin Inhibits Mast Cell-Mediated Allergic Inflammation","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106500_b0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-4939-7113-8_14","article-title":"Detection of Infiltrating Mast Cells Using a Modified Toluidine Blue Staining","volume":"1627","author":"Puebla-Osorio","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2020.106500_b0130","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.3390\/molecules23113039","article-title":"Coptisine Suppresses Mast Cell Degranulation and Ovalbumin-Induced Allergic Rhinitis","volume":"23","author":"Fu","year":"2018","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.intimp.2020.106500_b0135","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1172\/JCI87492","article-title":"Mast cell desensitization inhibits calcium flux and aberrantly remodels actin","volume":"126","author":"Ang","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2020.106500_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2017.04.017","article-title":"Betaeta-eudesmol reduces stem cell factor-induced mast cell migration","volume":"48","author":"Nam","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106500_b0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13601-018-0213-z","article-title":"Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE(+) B cells","volume":"8","author":"Hu","year":"2018","journal-title":"Clin. Transl. Allergy."},{"issue":"6","key":"10.1016\/j.intimp.2020.106500_b0150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1615\/CritRevImmunol.v31.i6.30","article-title":"Regulation of mast cell responses in health and disease","volume":"31","author":"Gilfillan","year":"2011","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.106500_b0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2017.10.012","article-title":"New roles and controls of mast cells","volume":"50","author":"Espinosa","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2020.106500_b0160","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2015.05.071","article-title":"Mast cell stabilisers","volume":"778","author":"Zhang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2020.106500_b0165","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1398-9995.2005.00832.x","article-title":"Molecular and cellular targets of anti-IgE antibodies","volume":"60","author":"Infuhr","year":"2005","journal-title":"Allergy"},{"issue":"S1","key":"10.1016\/j.intimp.2020.106500_b0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bjp.0706440","article-title":"Histamine and its receptors","volume":"147","author":"Parsons","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2020.106500_b0175","first-page":"CD011801","article-title":"Different oral corticosteroid regimens for acute asthma","volume":"13","author":"Normansell","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.intimp.2020.106500_b0180","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00011-004-1307-8","article-title":"Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids","volume":"53","author":"Schramm","year":"2004","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.106500_b0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","article-title":"Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis","volume":"65","author":"Bielory","year":"2005","journal-title":"Drugs."},{"issue":"1","key":"10.1016\/j.intimp.2020.106500_b0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-013-8365-z","article-title":"Hypersensitivity reactions to corticosteroids","volume":"47","author":"Vatti","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106500_b0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2020.106500_b0200","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0006-3223(86)90219-2","article-title":"Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide","volume":"21","author":"Tecott","year":"1986","journal-title":"Biol. Psychiatry"},{"issue":"79","key":"10.1016\/j.intimp.2020.106500_b0205","doi-asserted-by":"crossref","first-page":"34889","DOI":"10.18632\/oncotarget.26175","article-title":"The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer","volume":"9","author":"Dakir","year":"2018","journal-title":"Oncotarget."},{"issue":"5","key":"10.1016\/j.intimp.2020.106500_b0210","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1186\/ar4329","article-title":"Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy","volume":"15","author":"Liao","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2020.106500_b0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.taap.2017.07.015","article-title":"Suppression of IgE-mediated mast cell activation and mouse anaphylaxis via inhibition of Syk activation by 8-formyl-7-hydroxy-4-methylcoumarin, 4mu8C","volume":"332","author":"Nam","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106500_b0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2014.01.018","article-title":"Mast cell progenitors: origin, development and migration to tissues","volume":"63","author":"Dahlin","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2020.106500_b0225","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3389\/fimmu.2019.00821","article-title":"Mast Cells and Their Progenitors in Allergic Asthma","volume":"10","author":"Mendez-Enriquez","year":"2019","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2020.106500_b0230","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.1600066","article-title":"IL-10 Enhances IgE-Mediated Mast Cell Responses and Is Essential for the Development of Experimental Food Allergy in IL-10-Deficient Mice","volume":"196","author":"Polukort","year":"2016","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2020.106500_b0235","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1398-9995.2012.02879.x.","article-title":"The interaction between Lyn and FcepsilonRIbeta is indispensable for FcepsilonRI-mediated human mast cell activation","volume":"67","author":"Okayama","year":"2012","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.intimp.2020.106500_b0240","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1172\/JCI18246","article-title":"IL-10 is critical for Th2 responses in a murine model of allergic dermatitis","volume":"112","author":"Laouini","year":"2003","journal-title":"J. Clin. Invest."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920302319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920302319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:49:56Z","timestamp":1778820596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920302319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":48,"alternative-id":["S1567576920302319"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106500","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antipsychotic drug pimozide inhibits IgE-mediated mast cell degranulation and migration","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106500"}}